-
Tax Considerations For Investors In Financially Distressed Cannabis Companies
Tuesday, April 18, 2023 - 5:14pm | 9231Read More...Thanks to maturing markets, limited access to capital, and disproportionate tax burdens, many companies in the cannabis industry are facing major challenges in managing their debt. Creditors and investors are increasingly negotiating restructuring and refinancing agreements that allow distressed...
-
GW Pharmaceuticals Takeover Talk 'Seems A Bit Premature'
Thursday, September 8, 2016 - 9:23am | 317Read More...Shares of GW Pharmaceuticals PLC - ADR (NASDAQ: GWPH) soared Wednesday from around $83 per share to close at $104.03 after Reuters reported the company is in talks with an investment banks to consider strategic alternatives. GW Pharmaceuticals is a developer of marijuana-based epilepsy...



